Acazicolcept

Source: Wikipedia, the free encyclopedia.
Acazicolcept
Clinical data
Other namesALPN-101
Legal status
Legal status
  • Investigational
Identifiers
CAS Number
UNII
ChEMBL

Acazicolcept (ALPN-101) is an experimental dual

ICOS antagonist developed by AbbVie.[1][2][3]

References